RxDoctor Payments Data

Charles Owen

Gastroenterology · Arlington, TXNPI 1316938103

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,413 of the $2,063 with a category attached, or 68.5%. Eli Lilly accounts for 77.5% of it on its own, with 10 other manufacturers making up the rest. 2023 is the largest year on record at $1,672, 6.4 times the $263 reported in 2019. That places this record below the midpoint for gastroenterology clinicians in TX, where the typical reported total is $3,104.

$2,063in general payments, 2019–2025

Across 43 payments — averaging $47.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$2K
  • AbbVie$134
  • Johnson & Johnson$118
  • Bristol Myers Squibb$67
  • Merck$39
  • Pfizer$27
  • plus $79 from 5 others
$414,639in research payments, 2019–2025

Across 16 payments — averaging $25,915 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bristol Myers Squibb$378K
  • Braintree Laboratories, Inc.$37K

What the payments were for

  • Travel & lodging$1,41368%
  • Food & beverage$65032%
  • Education$00%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,063 in reported general payments places this provider in the 40th percentile of 1,350 gastroenterology providers in Texas.

See all gastroenterology providers in Texas →

Other gastroenterology in Arlington

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →